Monday, 15 January 2018

Imaging Demyelination, but am I being a bit thick?

A new report suggests that there is a new imaging agent for demyelination.

If we can image demyelination, remyelination trials get a whole lot easier.

However you asked, Has this study in animals cracked the nut?
Updated

Future Directions for Laboratory Animal Law in the US

Animals in Research is an Integral part of MS research.

Like or Loathe it, it is occurring, but times are changing.

Do you want to listen to a Day Webinar?

Future Directions for Laboratory Animal Law in the United States


Sunday, 14 January 2018

Making T reg cells. Explaining the daclizumab conundrum

How does daclicumab work?

Are immunologists fudging the mechanisms to keep dogma alive?

Friday, 12 January 2018

Newsflash: the wait is over ocrelizumab finally gets its EU marketing authorisation

If you have PPMS, and live in Europe, you are one step closer to having a disease-modifying therapy for your MS.


Guest post: FAIR data for next generation management of MS

Transforming the population based management of today into an individualized, personalized and precision level management is a major goal in research. I believe, the key to reach this next level is FAIR data.

Thursday, 11 January 2018

Guest post: Familial MS: do your genes seal your fate?

MS is not considered a hereditary disorder, as there is no specific gene transmitted from parent to child that causes the disease (not yet confirmed! We've covered the topic on the blog before). However, around 20% of people with MS report another family member with the condition and the risk differs depending on the degree of relatedness.



Wednesday, 10 January 2018